Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001997 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals
A NA study, sponsored by Chiron Corporation.
- Completed
- Registry status
- NA
- Development phase
NCT00001997: Completed NA study, sponsored by Chiron Corporation.
NCT00001997 is a NA study that has completed, run by Chiron Corporation. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001997, a NA study, has completed, sponsored by Chiron Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To investigate the safety of polyethylene glycolated interleukin-2 (PEG IL-2) given subcutaneously in conjunction with antiviral treatment and to explore the effects of treatment on surrogate markers of efficacy and incidence of opportunistic infection and other clinical markers of HIV disease.
Interventions
- DRUG Zidovudine
- DRUG Didanosine
- DRUG Interleukin-2, Polyethylene Glycolated
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00001997 record still lists
NCT00001997 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which Zidovudine is the first listed.
NCT00001997 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001997 about?
NCT00001997 is a clinical study titled "Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals". To investigate the safety of polyethylene glycolated interleukin-2 (PEG IL-2) given subcutaneously in conjunction with antiviral treatment and to explore the effects of treatment on surrogate markers of efficacy and incidence of opportunistic infection and other clinical markers of HIV disease.
What is the current status of trial NCT00001997?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00001997?
The interventions under investigation include: Zidovudine (DRUG), Didanosine (DRUG), Interleukin-2, Polyethylene Glycolated (DRUG).
Who is sponsoring clinical trial NCT00001997?
This trial is sponsored by Chiron Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.